X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26480) 26480
Magazine Article (267) 267
Newsletter (130) 130
Newspaper Article (32) 32
Book / eBook (13) 13
Web Resource (8) 8
Streaming Video (6) 6
Book Chapter (5) 5
Dissertation (5) 5
Government Document (5) 5
Book Review (3) 3
Conference Proceeding (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23515) 23515
antitubercular agents - therapeutic use (19855) 19855
male (11148) 11148
female (10851) 10851
adult (9522) 9522
tuberculosis (9112) 9112
middle aged (6928) 6928
tuberculosis, pulmonary - drug therapy (6408) 6408
tuberculosis - drug therapy (5107) 5107
infectious diseases (4122) 4122
adolescent (4102) 4102
treatment outcome (3913) 3913
aged (3773) 3773
anti-bacterial agents - therapeutic use (3695) 3695
mycobacterium tuberculosis - drug effects (3430) 3430
antibiotics, antitubercular (3358) 3358
drug therapy, combination (3093) 3093
child (2869) 2869
isoniazid - therapeutic use (2631) 2631
respiratory system (2630) 2630
mycobacterium tuberculosis - isolation & purification (2561) 2561
tuberculosis, multidrug-resistant - drug therapy (2489) 2489
dermatologic agents (2418) 2418
antitubercular agents - pharmacology (2405) 2405
antitubercular agents (2210) 2210
antitubercular agents - administration & dosage (2158) 2158
rifampin - therapeutic use (2157) 2157
microbiology (2097) 2097
mycobacterium-tuberculosis (2062) 2062
retrospective studies (2058) 2058
risk factors (1975) 1975
pulmonary tuberculosis (1953) 1953
young adult (1925) 1925
animals (1859) 1859
antitubercular agents - adverse effects (1727) 1727
pharmacology & pharmacy (1720) 1720
drug resistance (1716) 1716
time factors (1716) 1716
tuberculosis - diagnosis (1709) 1709
child, preschool (1700) 1700
mycobacterium tuberculosis (1698) 1698
medicine, general & internal (1683) 1683
tuberculosis, pulmonary - diagnosis (1681) 1681
diagnosis (1671) 1671
tuberculosis - epidemiology (1670) 1670
immunology (1585) 1585
drug therapy (1581) 1581
microbial sensitivity tests (1572) 1572
diagnosis, differential (1558) 1558
infant (1477) 1477
follow-up studies (1414) 1414
tuberculosis, pulmonary - microbiology (1368) 1368
care and treatment (1320) 1320
tuberculosis, pulmonary - epidemiology (1293) 1293
sputum - microbiology (1271) 1271
tuberculosis - prevention & control (1245) 1245
hiv (1221) 1221
tuberculosis, multidrug-resistant - epidemiology (1188) 1188
infection (1172) 1172
tuberculosis, pulmonary - complications (1139) 1139
research (1127) 1127
mycobacterium tuberculosis - genetics (1085) 1085
health aspects (1070) 1070
prevalence (1059) 1059
drug resistance, microbial (1053) 1053
analysis (1052) 1052
tomography, x-ray computed (1025) 1025
hiv infections - complications (1023) 1023
tuberculosis - microbiology (1017) 1017
incidence (1003) 1003
rifampin (999) 999
ethambutol - therapeutic use (996) 996
medicine (989) 989
research article (988) 988
tuberculin test (962) 962
drugs (955) 955
pyrazinamide - therapeutic use (953) 953
tuberculosis - complications (941) 941
aged, 80 and over (918) 918
hiv infections - drug therapy (887) 887
isoniazid (887) 887
radiography (866) 866
epidemiology (862) 862
prospective studies (858) 858
infections (842) 842
tuberculosis, multidrug-resistant - microbiology (837) 837
mice (824) 824
patients (824) 824
therapy (824) 824
disease (807) 807
antibiotics, antitubercular - therapeutic use (800) 800
mortality (798) 798
recurrence (784) 784
chemotherapy (777) 777
drug resistance in microorganisms (745) 745
public health (737) 737
public, environmental & occupational health (711) 711
aids-related opportunistic infections - drug therapy (705) 705
tuberculosis, multidrug-resistant - diagnosis (689) 689
multidrug-resistant tuberculosis (677) 677
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20056) 20056
Russian (1626) 1626
French (1477) 1477
German (1119) 1119
Spanish (773) 773
Italian (505) 505
Japanese (396) 396
Polish (313) 313
Romanian (253) 253
Chinese (189) 189
Portuguese (114) 114
Dutch (87) 87
Croatian (65) 65
Czech (44) 44
Swedish (44) 44
Turkish (43) 43
Danish (37) 37
Ukrainian (36) 36
Hungarian (32) 32
Hebrew (27) 27
Serbian (24) 24
Finnish (22) 22
Norwegian (16) 16
Slovak (14) 14
Korean (10) 10
Bulgarian (9) 9
Lithuanian (7) 7
Bosnian (3) 3
Slovenian (2) 2
Afrikaans (1) 1
Icelandic (1) 1
Vietnamese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medical research and opinion, ISSN 1473-4877, 2012, Volume 29, Issue 1, pp. 1 - 12
...-related protease inhibitors. Rifabutin reduces serum concentrations of antiretroviral agents, but less so than rifampin... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | PHARMACOKINETICS | METABOLISM | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and The Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet (British edition), ISSN 0140-6736, 2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 367 - 387
Summary HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs... 
Internal Medicine | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | OPIOID SUBSTITUTION TREATMENT | HEPATITIS-C VIRUS | SMOKING-CESSATION PHARMACOTHERAPIES | CLINICAL-TRIAL | TREATMENT OUTCOMES | METHADONE-MAINTENANCE | ADMINISTERED ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV Infections - epidemiology | Humans | Drug Resistance, Bacterial | Narcotics - therapeutic use | Criminal Law | Anti-HIV Agents - administration & dosage | Hepatitis, Viral, Human - epidemiology | Drug Interactions | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Tuberculosis - drug therapy | Anti-HIV Agents - therapeutic use | HIV Infections - mortality | Substance-Related Disorders - mortality | Antitubercular Agents - therapeutic use | Mental Disorders - epidemiology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Evidence-Based Medicine | Narcotics - administration & dosage | Medication Adherence | Mental Disorders - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Bacterial Infections - epidemiology | HIV Infections - drug therapy | Substance-Related Disorders - drug therapy | Hepatitis, Viral, Human - drug therapy | Prisoners | Prevention | Complications and side effects | Drug addicts | Research | Drug therapy | Health aspects | HIV infection | Mental illness | Risk factors | Cardiovascular diseases
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 10/2010, Volume 16, Issue 10, pp. 1546 - 1553
Journal Article
by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Major and Brief Reports
Journal Article